查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2077750

2026年全球免疫測量生物標記檢測計畫擴展市場報告

Immunoassay Biomarker Test Menu Expansion Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，利用免疫檢測法擴展免疫測量標記檢測範圍的市場規模迅速成長。預計該市場將從2025年的5.3億美元成長到2026年的6億美元，複合年成長率（CAGR）為12.2%。這一成長主要歸因於慢性病和感染疾病病率的上升、臨床檢查室對基於免疫檢測的診斷技術的日益普及、醫院診斷基礎設施和檢查室網路的擴展、人們對疾病早期檢測和預防醫學意識的提高，以及政府對診斷研究和檢查室現代化建設投入的增加。

未來幾年，利用免疫檢測方法擴展免疫測量標記檢測範圍的市場規模預計將快速成長。預計到2030年，該市場規模將達到9.5億美元，複合年成長率（CAGR）為12.4%。預測期內的成長預計將受到以下因素的驅動：精準醫療和個人化生物標記分析需求的不斷成長；人工智慧和自動化技術在診斷檢查室中的應用；伴隨診斷在藥物開發平臺中的應用；多參數和高通量檢測平台的日益普及；以及對癌症和慢性病早期檢測項目的日益關注。預測期內的關鍵趨勢包括：利用多種生物標記進行疾病檢測的多條帶免疫檢測試劑盒的擴展；高靈敏度化學冷光免疫檢測分析平台的快速發展；以個性化醫療主導的生物標記檢測解決方案的日益普及；用於高通量檢測的自動化免疫檢測分析儀整合技術的進步標誌；以及腫瘤學和感染疾病對生物普及物檢測需求的不斷成長標誌物。

慢性病和文明病的日益普遍預計將免疫測量免疫檢測檢測市場的成長。慢性病和文明病是指持續時間較長且需要持續醫療照護的長期健康狀況，例如心臟病、糖尿病、肥胖症和高血壓。這些疾病盛行率的上升是由人口老化和生活方式相關的風險因素（例如不良飲食習慣和缺乏運動）所驅動的，這些因素顯著加重了慢性病的負擔。擴大免疫分析免疫檢測檢測免疫測量將提高檢測實驗室的疾病檢測能力，使其能夠識別與這些疾病相關的更廣泛的生物標記物，從而支持早期診斷、後續觀察和改進臨床決策。例如，根據美國疾病管制與預防中心（CDC，美國政府公共衛生機構）的數據，到2023年，76.4%的美國成年人將至少患有一種慢性病，這意味著超過1.94億成年人將面臨需要定期監測和管理的健康問題。因此，慢性病和文明病的日益普遍預計將促進和支持使用免疫檢測方法擴大免疫測量生物標記測試範圍的市場成長。

在不斷成長的免疫檢測標記檢測市場中，領先企業正致力於開發先進的自動化免疫檢測平台，例如全整合免疫檢測系統，該系統可在單一自動化工作流程中簡化檢體處理和結果報告。這降低了操作人員的差異性，並提高了檢查室的處理能力。自動化免疫檢測平台是指透過機器人或自動化分析儀執行免疫檢測測試，以最大限度地減少人工干預的系統。這些機器人或分析儀可管理樣本製備、試劑混合、孵育、檢測和結果輸出，從而提高臨床環境中的一致性和測試反應速度。例如，2024年5月，總部位於法國的醫療技術公司bioMerieux推出了適用於其自動化免疫檢測平台VIDAS 3和VIDAS KUBE的VIDA TBI（GFAP、UCH-L1）檢測。該檢測具有創傷性腦損傷生物標記的高靈敏度、全天候按需自動化工作流程支援和快速結果報告功能，有助於高效的臨床分診並減少不必要的影像檢查。此次發布進一步增強了生物梅里埃的免疫檢測產品組合，擴展了其神經系統生物標記產品線，並滿足了急診醫學領域對快速診斷解決方案日益成長的需求。此外，該產品能夠及時、準確地檢測腦損傷，透過加強患者管理和最佳化醫療資源利用，從而支持更有效率的臨床決策。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球免疫測量生物標記檢測項目擴展市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 生物技術、基因組學和精準醫療
    • 數位化、雲端運算、巨量資料、網路安全
    • 人工智慧和自主智慧
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施、互聯生態系統
  • 主要趨勢
    • 利用多種生物標記擴展多參數免疫檢測組合以進行疾病檢測
    • 高靈敏度化學冷光免疫檢測平台開發進展
    • 個人化醫療推動生物標記檢測解決方案的廣泛應用。
    • 高通量檢測自動化臨床免疫檢測系統整合的進展。
    • 對癌症和感染疾病標記檢測的需求日益成長

第5章 終端用戶產業市場分析

  • 製藥和生物技術公司
  • 受託研究機構
  • 臨床和診斷檢查室
  • 學術和研究機構
  • 其他最終用戶

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球免疫測量生物標記檢測專案擴展市場：PESTEL 分析
  • 全球免疫測量生物標記檢測專案擴展市場：規模、對比及成長率分析
  • 全球免疫測量生物標記檢測計畫擴展市場表現：規模與成長，2020-2025年
  • 全球免疫測量生物標記檢測計畫擴展市場預測：規模與成長，2025-2030年，2035年

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 按類型
  • 酵素免疫分析法(ELISA) 試劑盒、化學冷光免疫檢測盒、螢光免疫分析盒、多參數免疫檢測板、快速診斷檢測套組、生物標記特異性試劑、校正標準品和品管樣本。
  • 依生物標誌類型
  • 腫瘤生物標記、心臟生物標記、內分泌和荷爾蒙生物標記、感染疾病標記、自體免疫疾病生物標記、神經系統生物標記、治療藥物監測生物標記物
  • 按年級
  • 高效液相層析(HPLC) 和超高效液相層析法(UHPLC) 級試劑、氣相層析法(GC) 級試劑、分析級試劑、液相層析質譜儀 (LC-MS) 級試劑、製備級試劑、生物技術級試劑和工業級過濾產品。
  • 透過使用
  • 臨床診斷、伴隨診斷、個人化醫療、藥物發現與臨床研究。
  • 最終用戶
  • 製藥和生物技術公司、合約研究組織 (CRO)、委託製造組織 (CMO)、學術和研究機構、臨床和診斷檢測實驗室、食品和飲料檢測實驗室、環境檢測實驗室、政府和監管機構、化學和工業製造公司
  • 按類型細分：酵素免疫分析法（ELISA）試劑盒
  • 夾心法檢測試劑盒、競賽法檢測試劑盒、間接法檢測試劑盒、直接法檢測試劑盒
  • 按類型細分：化學冷光免疫檢測試劑盒
  • 磁珠法試劑盒、固相法試劑盒、微孔盤法試劑盒、自動化分析儀試劑盒
  • 依類型細分：螢光免疫分析法盒
  • 時間分辨螢光盒、側向流動螢光盒、微珠法以微珠為基礎盒、多重螢光盒
  • 按類型細分：多重免疫檢測板
  • 細胞激素檢測、心臟標記檢測、腫瘤檢測、感染疾病檢測
  • 按類型細分：快速診斷試劑盒
  • 側向流動免疫檢測、膠體金檢測套組、微流體快速檢測套組、紙基診斷試劑盒
  • 按類型細分：生物標記特異性試劑
  • 抗體、抗原、結合物、檢測試劑
  • 按類型細分：校準參考物質
  • 蛋白質標準品、胜肽標準品、全血對照品、血清對照品
  • 按類型細分：品管材料
  • 正對照、負對照、內部對照、外部對照

第10章 區域與國別分析

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 免疫測量生物標記檢測專案擴展市場：競爭格局及市場佔有率（2024年）
  • 免疫測量生物標記檢測專案擴展市場：公司評估矩陣
  • 免疫測量生物標記檢測專案拓展市場：公司簡介
    • Tecan Trading AG
    • Euroimmun Medizinische Labordiagnostika AG
    • OPKO Health Inc.
    • Autobio Diagnostics Co. Ltd.
    • Promega Corporation

第37章 其他大型企業和創新企業

  • BioLegend Inc., Sekisui Diagnostics LLC, Boditech Med Inc., Dynex Technologies Inc., QuantuMDx Group Ltd., NanoEntek, J. Mitra & Co. Pvt. Ltd., Baebies, ALPCO Diagnostics, Micropoint Bioscience, Coris BioConcept, MiCo BioMed Inc., Kamiya Biomedical Company, Abionic SA, ANP Technologies Inc.

第38章：全球市場競爭基準分析與儀錶板

第39章：預計進入市場的新創企業

第40章 重大併購

第41章 具有高市場潛力的國家、細分市場與策略

  • 2030 年免疫測量生物標記檢測計畫擴展市場：提供新機會的國家。
  • 2030年免疫測量生物標記檢測專案擴展市場：提供新機會的細分市場
  • 2030年免疫測量生物標記檢測專案範圍擴展市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第42章附錄

簡介目錄
Product Code: MC4MIEMF01_G26Q2

Immunoassay biomarker test menu expansion refers to the process of broadening the range of biomarkers that can be detected and quantified using immunoassay techniques. It involves the development of new assays or the modification of existing ones to improve diagnostic capabilities and strengthen disease detection and monitoring. This expansion enables laboratories and healthcare providers to deliver more comprehensive testing solutions for accurate and timely clinical decision-making.

The primary types of immunoassay biomarker test menu expansion include enzyme-linked immunosorbent assay kits, chemiluminescent immunoassay kits, fluorescent immunoassay kits, multiplex immunoassay panels, rapid diagnostic test kits, biomarker-specific reagents, calibration standards, and quality control materials. Enzyme-linked immunosorbent assay kits refer to antibody-based detection systems used to detect and quantify specific biomarkers in biological samples for clinical and research applications. These involve various biomarker types such as oncology biomarkers, cardiac biomarkers, endocrine and hormonal biomarkers, infectious disease biomarkers, autoimmune disease biomarkers, neurological biomarkers, and therapeutic drug monitoring biomarkers, and they are categorized by grades including high performance liquid chromatography and ultra high performance liquid chromatography grade reagents, gas chromatography grade reagents, analytical grade reagents, liquid chromatography-mass spectrometry grade reagents, preparative grade reagents, biotechnology grade reagents, and technical grade filtration products. The various applications include clinical diagnostics, companion diagnostics, personalized medicine, and drug discovery and clinical research, and they are utilized by several end users such as pharmaceutical and biotechnology companies, contract research organizations, contract manufacturing organizations, academic and research institutions, clinical and diagnostic laboratories, food and beverage testing laboratories, environmental testing laboratories, government and regulatory agencies, and chemical and industrial manufacturing companies.

Tariffs are affecting the immunoassay biomarker test menu expansion market by raising the cost of imported reagents, assay kits, antibodies, and specialized diagnostic instruments used in laboratory testing. This is resulting in increased operational costs for clinical and research laboratories and slowing the adoption of advanced multiplex and biomarker-specific assays, particularly in import-dependent regions such as Asia-Pacific and Latin America. Segments including chemiluminescent immunoassay kits and biomarker-specific reagents are the most impacted due to their reliance on high-precision imported components. However, tariffs are also encouraging local reagent manufacturing, strengthening regional diagnostic supply chains, and accelerating domestic innovation in immunoassay technologies.

The immunoassay biomarker test menu expansion market research report is one of a series of new reports from The Business Research Company that provides immunoassay biomarker test menu expansion market statistics, including immunoassay biomarker test menu expansion industry global market size, regional shares, competitors with a immunoassay biomarker test menu expansion market share, detailed immunoassay biomarker test menu expansion market segments, market trends and opportunities, and any further data you may need to thrive in the immunoassay biomarker test menu expansion industry. This immunoassay biomarker test menu expansion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The immunoassay biomarker test menu expansion market size has grown rapidly in recent years. It will grow from $0.53 billion in 2025 to $0.6 billion in 2026 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to increasing prevalence of chronic and infectious diseases, rising adoption of immunoassay based diagnostic technologies in clinical laboratories, expansion of hospital diagnostic infrastructure and lab networks, growing awareness of early disease detection and preventive healthcare, increasing government funding for diagnostic research and laboratory modernization.

The immunoassay biomarker test menu expansion market size is expected to see rapid growth in the next few years. It will grow to $0.95 billion by 2030 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to rising demand for precision medicine and personalized biomarker profiling, increasing integration of AI and automation in diagnostic laboratories, expansion of companion diagnostics in drug development pipelines, growing adoption of multiplex and high throughput testing platforms, increasing focus on early cancer and chronic disease detection programs. Major trends in the forecast period include expansion of multiplex immunoassay panels for multi biomarker disease detection, increasing development of high sensitivity chemiluminescent immunoassay platforms, rising adoption of personalized medicine driven biomarker testing solutions, growing integration of automated laboratory immunoassay analyzers for high throughput testing, increasing demand for oncology and infectious disease biomarker assay expansion.

The increasing prevalence of chronic and lifestyle diseases is expected to propel the growth of the immunoassay biomarker test menu expansion market going forward. Chronic and lifestyle diseases are long-term health conditions such as heart disease, diabetes, obesity, and hypertension that persist over extended periods and require continuous medical care. The rising prevalence of these diseases is driven by aging populations and lifestyle-related risk factors such as poor dietary habits and physical inactivity, which are significantly contributing to the growing burden of chronic health conditions. Immunoassay biomarker test menu expansion supports enhanced disease detection by enabling laboratories to identify a broader range of disease-associated biomarkers, thereby improving early diagnosis, monitoring, and clinical decision-making. For instance, in April 2025, according to the US Centers for Disease Control and Prevention, a US-based government public health agency, in 2023, 76.4% of US adults reported at least one chronic condition, representing more than 194 million adults with ongoing health conditions that require regular monitoring and management. Therefore, the increasing prevalence of chronic and lifestyle diseases is expected to propel and support the growth of the immunoassay biomarker test menu expansion market.

Leading companies operating in the immunoassay biomarker test menu expansion market are focusing on developing advanced automated immunoassay panels, such as fully integrated immunoassay systems that streamline sample handling and result reporting within a single automated workflow, to reduce operator variability and increase laboratory throughput. Automated immunoassay panels are systems in which immunoassay tests are performed with minimal manual intervention through robotics or automated analyzers that manage sample preparation, reagent mixing, incubation, detection, and result output, improving consistency and turnaround time in clinical settings. For example, in May 2024, bioMerieux, a France-based healthcare technology company, launched the VIDA TBI (GFAP, UCH-L1) test for its automated immunoassay platforms VIDAS 3 and VIDAS KUBE, featuring high sensitivity for traumatic brain injury biomarkers, compatibility with on-demand automated workflows 24/7, and rapid result turnaround, aiding efficient clinical triage and reducing unnecessary imaging. The launch strengthens bioMerieux's immunoassay test menu by expanding its neurological biomarker portfolio and addressing growing demand for rapid diagnostic solutions in emergency care settings. Additionally, it supports improved clinical decision-making by enabling timely and accurate detection of brain injury, enhancing patient management, and optimizing healthcare resource utilization.

In July 2024, Roche, a Switzerland-based healthcare technology company, acquired LumiraDx's point-of-care technology business for an agreed purchase price of approximately $295 million plus up to $55 million in additional payments. With this acquisition, Roche aims to broaden its diagnostics portfolio by integrating a multi-assay point-of-care platform that combines immunoassay, clinical chemistry, and related tests, expanding access to decentralized diagnostic solutions and accelerating global testing capabilities in primary care. LumiraDx is a UK-based healthcare technology company specializing in an advanced point-of-care diagnostic platform capable of running a wide range of immunoassay and clinical chemistry tests on a single instrument, with potential for further molecular testing expansion.

Major companies operating in the immunoassay biomarker test menu expansion market are Tecan Trading AG, Euroimmun Medizinische Labordiagnostika AG, OPKO Health Inc. , Autobio Diagnostics Co. Ltd. , Promega Corporation, BioLegend Inc. , Sekisui Diagnostics LLC, Boditech Med Inc. , Dynex Technologies Inc. , QuantuMDx Group Ltd. , NanoEntek, J. Mitra & Co. Pvt. Ltd. , Baebies, ALPCO Diagnostics, Micropoint Bioscience, Coris BioConcept, MiCo BioMed Inc. , Kamiya Biomedical Company, Abionic SA, ANP Technologies Inc. , Axis-Biosciences / Axela, Epitope Diagnostics Inc. , MedMira Inc. , Nanomix Inc.

North America was the largest region in the immunoassay biomarker test menu expansion market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immunoassay biomarker test menu expansion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the immunoassay biomarker test menu expansion market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The immunoassay biomarker test menu expansion market consists of sales of enzyme-linked immunosorbent assay kits, chemiluminescent immunoassay kits, fluorescent immunoassay kits, multiplex immunoassay panels, rapid diagnostic test kits, biomarker-specific reagents, calibration standards, and quality control materials. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunoassay Biomarker Test Menu Expansion Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses immunoassay biomarker test menu expansion market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunoassay biomarker test menu expansion ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The immunoassay biomarker test menu expansion market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Enzyme-Linked Immunosorbent Assay Kits; Chemiluminescent Immunoassay Kits; Fluorescent Immunoassay Kits; Multiplex Immunoassay Panels; Rapid Diagnostic Test Kits; Biomarker-Specific Reagents; Calibration Standards; Quality Control Materials
  • 2) By Biomarker Type: Oncology Biomarkers; Cardiac Biomarkers; Endocrine And Hormonal Biomarkers; Infectious Disease Biomarkers; Autoimmune Disease Biomarkers; Neurological Biomarkers; Therapeutic Drug Monitoring Biomarkers
  • 3) By Grade: High-Performance Liquid Chromatography (HPLC) And Ultra-High-Performance Liquid Chromatography (UHPLC) Grade Reagents; Gas Chromatography (GC) Grade Reagents; Analytical Grade Reagents; Liquid Chromatography-Mass Spectrometry (LC-MS) Grade Reagents; Preparative Grade Reagents; Biotechnology Grade Reagents; Technical Grade Filtration Products
  • 4) By Application: Clinical Diagnostics; Companion Diagnostics; Personalized Medicine; Drug Discovery And Clinical Research
  • 5) By End-User: Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Contract Manufacturing Organizations; Academic And Research Institutions; Clinical And Diagnostic Laboratories; Food And Beverage Testing Laboratories; Environmental Testing Laboratories; Government And Regulatory Agencies; Chemical And Industrial Manufacturing Companies
  • Subsegments:
  • 1) By Enzyme-Linked Immunosorbent Assay Kits: Sandwich Assay Kits; Competitive Assay Kits; Indirect Assay Kits; Direct Assay Kits
  • 2) By Chemiluminescent Immunoassay Kits: Magnetic Particle-Based Kits; Solid Phase Kits; Microplate-Based Kits; Automated Analyzer Kits
  • 3) By Fluorescent Immunoassay Kits: Time-Resolved Fluorescence Kits; Lateral Flow Fluorescence Kits; Microbead-Based Kits; Multiplex Fluorescence Kits
  • 4) By Multiplex Immunoassay Panels: Cytokine Panels; Cardiac Marker Panels; Oncology Panels; Infectious Disease Panels
  • 5) By Rapid Diagnostic Test Kits: Lateral Flow Immunoassays; Colloidal Gold Test Kits; Microfluidic Rapid Kits; Paper-Based Diagnostic Kits
  • 6) By Biomarker-Specific Reagents: Antibodies; Antigens; Conjugates; Detection Reagents
  • 7) By Calibration Standards: Protein Standards; Peptide Standards; Whole Blood Controls; Serum Controls
  • 8) By Quality Control Materials: Positive Controls; Negative Controls; Internal Controls; External Controls
  • Companies Mentioned: Tecan Trading AG; Euroimmun Medizinische Labordiagnostika AG; OPKO Health Inc.; Autobio Diagnostics Co. Ltd.; Promega Corporation; BioLegend Inc.; Sekisui Diagnostics LLC; Boditech Med Inc.; Dynex Technologies Inc.; QuantuMDx Group Ltd.; NanoEntek; J. Mitra & Co. Pvt. Ltd.; Baebies; ALPCO Diagnostics; Micropoint Bioscience; Coris BioConcept; MiCo BioMed Inc.; Kamiya Biomedical Company; Abionic SA; ANP Technologies Inc.; Axis-Biosciences / Axela; Epitope Diagnostics Inc.; MedMira Inc.; Nanomix Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Immunoassay Biomarker Test Menu Expansion Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Immunoassay Biomarker Test Menu Expansion Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Immunoassay Biomarker Test Menu Expansion Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Immunoassay Biomarker Test Menu Expansion Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Expansion Of Multiplex Immunoassay Panels For Multi Biomarker Disease Detection
    • 4.2.2 Increasing Development Of High Sensitivity Chemiluminescent Immunoassay Platforms
    • 4.2.3 Rising Adoption Of Personalized Medicine Driven Biomarker Testing Solutions
    • 4.2.4 Growing Integration Of Automated Laboratory Immunoassay Analyzers For High Throughput Testing
    • 4.2.5 Increasing Demand For Oncology And Infectious Disease Biomarker Assay Expansion

5. Immunoassay Biomarker Test Menu Expansion Market Analysis Of End Use Industries

  • 5.1 Pharmaceutical And Biotechnology Companies
  • 5.2 Contract Research Organizations
  • 5.3 Clinical And Diagnostic Laboratories
  • 5.4 Academic And Research Institutions
  • 5.5 Other End Users

6. Immunoassay Biomarker Test Menu Expansion Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Immunoassay Biomarker Test Menu Expansion Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Immunoassay Biomarker Test Menu Expansion PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Immunoassay Biomarker Test Menu Expansion Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Immunoassay Biomarker Test Menu Expansion Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Immunoassay Biomarker Test Menu Expansion Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Immunoassay Biomarker Test Menu Expansion Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Immunoassay Biomarker Test Menu Expansion Market Segmentation

  • 9.1. Global Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Enzyme-Linked Immunosorbent Assay Kits, Chemiluminescent Immunoassay Kits, Fluorescent Immunoassay Kits, Multiplex Immunoassay Panels, Rapid Diagnostic Test Kits, Biomarker-Specific Reagents, Calibration Standards, Quality Control Materials
  • 9.2. Global Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oncology Biomarkers, Cardiac Biomarkers, Endocrine And Hormonal Biomarkers, Infectious Disease Biomarkers, Autoimmune Disease Biomarkers, Neurological Biomarkers, Therapeutic Drug Monitoring Biomarkers
  • 9.3. Global Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • High-Performance Liquid Chromatography (HPLC) And Ultra-High-Performance Liquid Chromatography (UHPLC) Grade Reagents, Gas Chromatography (GC) Grade Reagents, Analytical Grade Reagents, Liquid Chromatography-Mass Spectrometry (LC-MS) Grade Reagents, Preparative Grade Reagents, Biotechnology Grade Reagents, Technical Grade Filtration Products
  • 9.4. Global Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Clinical Diagnostics, Companion Diagnostics, Personalized Medicine, Drug Discovery And Clinical Research
  • 9.5. Global Immunoassay Biomarker Test Menu Expansion Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Contract Manufacturing Organizations, Academic And Research Institutions, Clinical And Diagnostic Laboratories, Food And Beverage Testing Laboratories, Environmental Testing Laboratories, Government And Regulatory Agencies, Chemical And Industrial Manufacturing Companies
  • 9.6. Global Immunoassay Biomarker Test Menu Expansion Market, Sub-Segmentation Of Enzyme-Linked Immunosorbent Assay Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Sandwich Assay Kits, Competitive Assay Kits, Indirect Assay Kits, Direct Assay Kits
  • 9.7. Global Immunoassay Biomarker Test Menu Expansion Market, Sub-Segmentation Of Chemiluminescent Immunoassay Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Magnetic Particle-Based Kits, Solid Phase Kits, Microplate-Based Kits, Automated Analyzer Kits
  • 9.8. Global Immunoassay Biomarker Test Menu Expansion Market, Sub-Segmentation Of Fluorescent Immunoassay Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Time-Resolved Fluorescence Kits, Lateral Flow Fluorescence Kits, Microbead-Based Kits, Multiplex Fluorescence Kits
  • 9.9. Global Immunoassay Biomarker Test Menu Expansion Market, Sub-Segmentation Of Multiplex Immunoassay Panels, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cytokine Panels, Cardiac Marker Panels, Oncology Panels, Infectious Disease Panels
  • 9.10. Global Immunoassay Biomarker Test Menu Expansion Market, Sub-Segmentation Of Rapid Diagnostic Test Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Lateral Flow Immunoassays, Colloidal Gold Test Kits, Microfluidic Rapid Kits, Paper-Based Diagnostic Kits
  • 9.11. Global Immunoassay Biomarker Test Menu Expansion Market, Sub-Segmentation Of Biomarker-Specific Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Antibodies, Antigens, Conjugates, Detection Reagents
  • 9.12. Global Immunoassay Biomarker Test Menu Expansion Market, Sub-Segmentation Of Calibration Standards, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Protein Standards, Peptide Standards, Whole Blood Controls, Serum Controls
  • 9.13. Global Immunoassay Biomarker Test Menu Expansion Market, Sub-Segmentation Of Quality Control Materials, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Positive Controls, Negative Controls, Internal Controls, External Controls

10. Immunoassay Biomarker Test Menu Expansion Market Regional And Country Analysis

  • 10.1. Global Immunoassay Biomarker Test Menu Expansion Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Immunoassay Biomarker Test Menu Expansion Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Immunoassay Biomarker Test Menu Expansion Market

  • 11.1. Asia-Pacific Immunoassay Biomarker Test Menu Expansion Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Immunoassay Biomarker Test Menu Expansion Market

  • 12.1. China Immunoassay Biomarker Test Menu Expansion Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Immunoassay Biomarker Test Menu Expansion Market

  • 13.1. India Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Immunoassay Biomarker Test Menu Expansion Market

  • 14.1. Japan Immunoassay Biomarker Test Menu Expansion Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Immunoassay Biomarker Test Menu Expansion Market

  • 15.1. Australia Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Immunoassay Biomarker Test Menu Expansion Market

  • 16.1. Indonesia Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Immunoassay Biomarker Test Menu Expansion Market

  • 17.1. South Korea Immunoassay Biomarker Test Menu Expansion Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Immunoassay Biomarker Test Menu Expansion Market

  • 18.1. Taiwan Immunoassay Biomarker Test Menu Expansion Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Immunoassay Biomarker Test Menu Expansion Market

  • 19.1. South East Asia Immunoassay Biomarker Test Menu Expansion Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Immunoassay Biomarker Test Menu Expansion Market

  • 20.1. Western Europe Immunoassay Biomarker Test Menu Expansion Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Immunoassay Biomarker Test Menu Expansion Market

  • 21.1. UK Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Immunoassay Biomarker Test Menu Expansion Market

  • 22.1. Germany Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Immunoassay Biomarker Test Menu Expansion Market

  • 23.1. France Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Immunoassay Biomarker Test Menu Expansion Market

  • 24.1. Italy Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Immunoassay Biomarker Test Menu Expansion Market

  • 25.1. Spain Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Immunoassay Biomarker Test Menu Expansion Market

  • 26.1. Eastern Europe Immunoassay Biomarker Test Menu Expansion Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Immunoassay Biomarker Test Menu Expansion Market

  • 27.1. Russia Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Immunoassay Biomarker Test Menu Expansion Market

  • 28.1. North America Immunoassay Biomarker Test Menu Expansion Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Immunoassay Biomarker Test Menu Expansion Market

  • 29.1. USA Immunoassay Biomarker Test Menu Expansion Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Immunoassay Biomarker Test Menu Expansion Market

  • 30.1. Canada Immunoassay Biomarker Test Menu Expansion Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Immunoassay Biomarker Test Menu Expansion Market

  • 31.1. South America Immunoassay Biomarker Test Menu Expansion Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Immunoassay Biomarker Test Menu Expansion Market

  • 32.1. Brazil Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Immunoassay Biomarker Test Menu Expansion Market

  • 33.1. Middle East Immunoassay Biomarker Test Menu Expansion Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Immunoassay Biomarker Test Menu Expansion Market

  • 34.1. Africa Immunoassay Biomarker Test Menu Expansion Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Immunoassay Biomarker Test Menu Expansion Market, Segmentation By Type, Segmentation By Biomarker Type, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Immunoassay Biomarker Test Menu Expansion Market Regulatory and Investment Landscape

36. Immunoassay Biomarker Test Menu Expansion Market Competitive Landscape And Company Profiles

  • 36.1. Immunoassay Biomarker Test Menu Expansion Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Immunoassay Biomarker Test Menu Expansion Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Immunoassay Biomarker Test Menu Expansion Market Company Profiles
    • 36.3.1. Tecan Trading AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Euroimmun Medizinische Labordiagnostika AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. OPKO Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Autobio Diagnostics Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Promega Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Immunoassay Biomarker Test Menu Expansion Market Other Major And Innovative Companies

  • BioLegend Inc., Sekisui Diagnostics LLC, Boditech Med Inc., Dynex Technologies Inc., QuantuMDx Group Ltd., NanoEntek, J. Mitra & Co. Pvt. Ltd., Baebies, ALPCO Diagnostics, Micropoint Bioscience, Coris BioConcept, MiCo BioMed Inc., Kamiya Biomedical Company, Abionic SA, ANP Technologies Inc.

38. Global Immunoassay Biomarker Test Menu Expansion Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Immunoassay Biomarker Test Menu Expansion Market

41. Immunoassay Biomarker Test Menu Expansion Market High Potential Countries, Segments and Strategies

  • 41.1 Immunoassay Biomarker Test Menu Expansion Market In 2030 - Countries Offering Most New Opportunities
  • 41.2 Immunoassay Biomarker Test Menu Expansion Market In 2030 - Segments Offering Most New Opportunities
  • 41.3 Immunoassay Biomarker Test Menu Expansion Market In 2030 - Growth Strategies
    • 41.3.1 Market Trend Based Strategies
    • 41.3.2 Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer